News Roche MS drug sales rise, but so does biosimilar threat Ocrevus shines as biosimilars bite in Europe
News Roche signs deal with Warp Drive to hasten antibiotic R&D Roche has signed a deal with Warp Drive Bio to discover and develop new antibiotics, badly needed to combat the growing threat of multi-drug resistant bacteria.
News Cancer drug could cost NHS £4.7m per year of patient life, s... Roche's Erivedge is latest cancer drug to fall foul of NICE number-crunching.
News FDA approves Roche's Zika blood test Test was first developed to screen blood supplies in Puerto Rico
News FDA rejects J&J's sirukumab RA drug The FDA has rejected Johnson & Johnson’s next-generation rheumatoid arthritis drug, sirukumab, calling for more clinical data to evaluate its safety.
Views & Analysis Pharma 2022: big pharma will remain a constant Pharma 2022: big pharma to maintain its position, ready to pounce on any newcomer that shows promise.
News UK offers meningitis jab to young people after outbreak The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
